Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: A survey on 299 outpatients;Couverture vaccinale antigrippale et antipneumococcique à partir de 65 ans : étude sur 299 patients ambulatoires

Revue de Medecine Interne

Volumn 30, Issue 8, 2009, Pages 656-660

  Delelis Fanien, A S ^a   Seite F ^a   Priner, M ^a   Paccalin, M ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adults; Geriatrics; Influenza; Pneumococcal; Vaccine coverage

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; DRUG INFORMATION; ELDERLY CARE; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFORMATION DISSEMINATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT ATTITUDE; PNEUMOCOCCAL INFECTION; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

AGED; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; INFLUENZA VACCINES; MALE; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE;

EID: 67651097736     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.12.026     Document Type: Article

References (25)

1. o 31-32.
2. Balinska M.A., and Leon C. Opinions et réticences face à la vaccination. Rev Med Interne 28 (2007) 28-32
3. Gaillat J., and Leophonte P. Vaccination pneumococcique : une prise de conscience ?. Rev Pneumol Clin 57 (2001) 3-5
4. Temime L., and Dab W. Vaccination antipneumococcique : bénéfices attendus chez l'adulte. Rev Med Interne 28 (2007) 9-15
5. Gaillat J. Epidémiologie des infections systémiques à Streptococcus pneumoniae. Presse Med 27 Suppl 1 (1998) 9-16
6. Les maladies infectieuses : la situation actuelle dans le monde. Disponible sur : www.pasteur.fr/actu/presse/com/dossier/malinfectieuses/situation.htm. Consulté en ligne le 5 novembre 2008.
7. Lina B., Holm M.V., and Szucs T.D. Evolution du taux de couverture vaccinale contre la grippe en France : de 2001 à 2006. Med Mal Infect 38 (2008) 125-132
8. WHO. Resolution of the World Health Assembly WHA 56.19, Prevention and control of influenza pandemics and annual epidemics. In 56th WHA, 10th plenary meeting. 2003.
9. Ridda I., Motbey C., Lam L., et al. Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude and knowledge. Vaccine 26 (2008) 234-240
10. Gil H., Bailly P., Meaux-Ruault N., Clement I., Floret N., Guiot A., et al. La vaccination antigrippale du personnel hospitalier. Enquête de prévalence au CHU de Besançon, hiver 2003-2004. Rev Med Interne 27 (2006) 5-9
11. Rothon-Tondeur M., de Wazieres B., Lejeune B., and Gavazzi G. Influenza vaccine coverage for healthcare workers in geriatric setting in France. Aging Clin Exp Res 18 (2006) 512-516
12. Murris-Espin M., Aubert M., Bosdure E., Weil-Olivier C., and Dubus J.C. Couverture vaccinale vis-à-vis de la grippe des soignants des douze Centres de ressources et de compétence de la mucoviscidose du Grand-Sud de la France en 2005-2006. Rev Mal Respir 25 (2008) 551-558
13. Dubois G. La vaccination pneumococcique en France chez l'adulte. Bull Acad Natl Med 186 (2002) 1461-1477
14. Jougla E., Hatten F., and Le Toullec A. Mortalité par maladie infectieuse en France. Med Mal Infect 27 (1997) 492-495
15. Harboe Z., Valentiner-Branth P., Benfield T., Christensen J., Hjuler T., Karltoft M., et al. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005. Vaccine 26 (2008) 3765-3771
16. Rosenheim M. Efficacité du vaccin polysaccharidique pneumococcique chez les sujets âgés. Rapport du comité technique des vaccinations ; décembre 2002.
17. Lopalco PL, Giesecke J. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Euro Surveill 2007;12:E070118.1.
18. Green C.M., Kyaw M.H., and Ray S.M. Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003. Clin Infect Dis 43 (2006) 141-150
19. Fedson D.S., and Liss C. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 25 (2004) 927-946
20. Ochoa-Gondar O., Vila-Corcoles A., Ansa X., Rodriguez-Blanco T., Salsench E., de Diego C., et al. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study. Vaccine 26 (2008) 1955-1962
21. Moberley S.A., Holden J., Tatham D.P., and Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1 (2008) CD000422
22. Lamontagne F., Garant M.P., Carvalho J.C., Lanthier L., Smieja M., and Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 179 (2008) 773-777
23. Christenson B., Lundbergh P., Hedlund J., and Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 357 (2001) 1008-1011
24. Hedlund J., Christenson B., Lundbergh P., and Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 21 (2003) 3906-3911
25. Lexeau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051